- E22.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E22.2 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E22.2 – other international versions of ICD-10 E22.2 may differ.
ICD-10-CM E22.2 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E22.2:
- antidiuretic > hormone (s) E27.0
- secretion > Inappropriate
- antidiuretic hormone (ADH) (excessive) > secretion E22.2
- pituitary (posterior) > secretion E22.2
- posterior > pituitary (gland) (anterior) (lobe) E22.9
- posterior lobe > pituitary gland E23.2
- antidiuretic hormone, inappropriate > Secretion
- hormone > Secretion
- antidiuretic, inappropriate (syndrome) > hormone E22.2
- inappropriate secretion of antidiuretic hormone > Syndrome
- Schwartz-Bartter > Syndrome